KeriCure
KeriCure Medical is a Tampa-based, woman-owned biotech company that develops and commercializes proprietary nanopolymer polyacrylate spray-on wound care products — combining silver hydrosol antimicrobials and lidocaine — for military, healthcare providers, elderly care, consumer, and veterinary markets.
- Company typePrivate
- Founded2011
- HeadquartersWesley Chapel, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What KeriCure does
KeriCure Medical is a woman-owned, privately-held biotechnology company founded in 2011 by Dr. Kerriann Greenhalgh and headquartered in Tampa, Florida. The company is built around a proprietary nanopolymer polyacrylate platform developed over 15+ years at the University of South Florida, which mimics the elasticity of natural skin (elastin) to form an oxygen-permeable, hypoallergenic barrier that supports moist wound healing. Core products — including Field Shield Wound Dressing (FDA 510(k) cleared in July 2024 and the first multi-use spray-on dressing combining silver hydrosol antimicrobial with lidocaine pain relief), Advanced Shield variants, Advanced Seal, and KeriCleanz antiseptic cleanser — combine the polyacrylate polymer with antimicrobial silver and, in select SKUs, topical lidocaine. A veterinary sub-brand (Tough Seal/Tough Shield) and private-label lines (SwineSeal, BioFilm Blast MD) extend the technology to adjacent markets.
KeriCure firmographics
Firmographics- Name
- KeriCure
- Legal name
- KeriCure Inc.
- Website
- https://kericuremedical.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- KeriCure Medical is a Tampa-based, woman-owned biotech company that develops and commercializes proprietary nanopolymer polyacrylate spray-on wound care products — combining silver hydrosol antimicrobials and lidocaine — for military, healthcare providers, elderly care, consumer, and veterinary markets.
- Ownership category
- akta.pro rank
KeriCure industry classification
Industry- Product category
- Advanced Wound Care Products
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)
- akta.pro secondary industries
- First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care) (CRADAMAB), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers) (HLAMAFAF)
Keywords
Where KeriCure is headquartered
LocationHeadquarters
- HQ city
- Wesley Chapel
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
KeriCure business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Product Sales - Consumer/Professional: Direct sales of advanced wound care products to consumers and healthcare professionals through e-commerce and provider ordering channels. Products include Advanced Seal, Advanced Shield, Field Shield, KeriCleanz, and veterinary lines.
- Government Contracts: Federal government sales through DAPA catalog and direct NSN procurement. Products sold to DoD, NATO, and other federal agencies for military and emergency medical use.
- Private Label/Licensing: Licensing of patented technology and private label manufacturing for partners including SwineTech (SwineSeal), InteliWound (BioFilm Blast MD), and Molly's Suds.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Military Grade Field Shield - Individual |
| Unit Pricing | Pay-as-you-go | Consumer Products - Individual |
| Unit Pricing | Pay-as-you-go | Provider Volume Ordering - Advanced Seal |
| Unit Pricing | Pay-as-you-go | Provider Volume Ordering - Advanced Shield MAX |
| Unit Pricing | Pay-as-you-go | Provider Volume Ordering - Field Shield Pro |
| Unit Pricing | Pay-as-you-go | Provider Volume Ordering - Advanced Shield Chronic |
| Unit Pricing | Pay-as-you-go | Provider Volume Ordering - KeriCleanz |
| Unit Pricing | Pay-as-you-go | Veterinary Products |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
KeriCure product offering
Product offeringCore offering
KeriCure Medical develops and sells proprietary nanopolymer polyacrylate-based spray-on wound care products that combine hydrogel moisture therapy with antimicrobial silver hydrosol and lidocaine for pain relief. The portfolio includes human wound care products (Advanced Seal, Advanced Shield MAX, Advanced Shield Chronic, Field Shield Pro, KeriCleanz) and veterinary lines (Tough Seal, Tough Shield) sold through consumer e-commerce, healthcare provider volume ordering, government contracts, military distributors, and private label licensing.
Product overview
KeriCure Medical is a woman-owned biotechnology company offering a comprehensive portfolio of spray-on wound care and skin barrier products based on patented nanopolymer technology. The core platform uses a proprietary polyacrylate polymer that mimics natural skin elasticity combined with silver hydrosol for antimicrobial protection. Key products include: Field Shield Pro (FDA 510(k) cleared, with silver and lidocaine for military/professional use); Advanced Shield variants (MAX for superior protection, Chronic for elderly/fragile skin care); Advanced Seal (basic wound barrier) and Advanced Seal Plus Pain Relief (with 2% lidocaine); KeriCleanz antiseptic wound cleanser; and Tough Seal/Tough Shield sub-brand for veterinary applications. Products are available in consumer, provider volume, and military-grade formulations with NSN designations for government procurement.
Differentiator
Problem solved
Functional benefit
Brands
- KeriChem Tech: FDA consulting service firm founded by Dr. Kerriann Greenhalgh in 2017, focusing on biotechnology, medical device and OTC drug new product development and transition to commercially viable products.
Products and services
- Field Shield Pro Wound Dressing FDA-cleared spray-on hydrogel wound dressing with silver hydrosol antimicrobial and lidocaine for pain relief. Creates a moist wound environment with a protective elastic polymer barrier that sets within 5 minutes of application. Targeted at healthcare providers and professional burn/wound care use.
- Military Grade Field Shield Wound Dressing Spray Military-formulated spray-on wound dressing with antimicrobial silver and lidocaine, designed for prolonged field care and Tactical Combat Casualty Care (TCCC). Available in 1oz and 0.5oz sizes with NSN designations for DoD, NATO, and federal procurement.
- Advanced Shield MAX Wound Barrier Spray-on wound barrier containing silver hydrosol and elastic polymer providing physical barrier against infection. Formed from polyacrylate nanoparticles mimicking natural skin elasticity. Consumer pricing from $40; provider case pricing from $1,050 (1oz spray).
- Advanced Shield Chronic Wound Barrier Wound barrier specifically designed for elderly skin and wound care needs. Addresses chronic wounds, pressure injuries, burns, surgical incisions, and diabetic wounds with hypoallergenic formula. Provider case pricing from $560 (2oz spray).
- Advanced Seal Wound Barrier Spray-on wound barrier and liquid bandage for first aid skin and wound protection. Waterproof and sweatproof elastic barrier ideal for minor cuts and scrapes after cleaning and disinfecting. Consumer pricing from $25; provider case pricing from $375 (case of 15).
- Advanced Seal plus Pain Relief (2% Lidocaine) Spray-on wound barrier with 2% lidocaine for topical relief of bug bites, rashes, poison ivy/oak, minor burns, and other painful or itchy skin concerns.
- KeriCleanz Antiseptic Wound Cleaner Topical antiseptic skin and wound cleanser spray containing 1% hydrogen peroxide enhanced with silver hydrosol. Disrupts biofilms and established infections to help begin the healing process. Provider pricing $450 for 15-bottle quantity (NSN 6505-01-727-2027).
- Tough Shield Liquid Bandage (with silver) Veterinary all-in-one antimicrobial spray-on liquid bandage with nanoparticle silver and vitamin E for cleaning and protecting animal wounds. Consumer pricing from $17.
- Tough Seal Liquid Bandage Veterinary spray-on liquid bandage designed for dogs, cats, and small animals. Forms breathable, waterproof barrier protecting wounds from dirt and germs while promoting moist wound healing. Consumer pricing from $15.
- Tough Seal Hot Spot + Pain (with lidocaine) Veterinary spray combining 1% lidocaine and ultra-hydrating hydrogel for instant relief of hot spots, rashes, inflammation, and allergic dermatitis in animals. Consumer pricing from $16.
Quantifiable outcome
- Patient compliance improved from 60% to 99% compared to traditional post-procedure wound care
- +3 more outcomes
Companies that use KeriCure
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles5 records
KeriCure technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
KeriCure partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered primary, secondary and minor.
- North American Rescue (NAR)primaryKeriCure Medical partnered with North American Rescue as their primary distributor for military grade products, Field Shield Wound Dressing and KeriCleanz Antiseptic Spray. NAR offers these compact, easy-to-apply products for wound and burn protection in prehospital and tactical settings serving military, law enforcement, first responders, and workplace safety markets.
- Coalition for National Trauma Research (CNTR)primaryNonprofit research coordinating center managing KeriCure's first clinical trial - a two-site trial comparing Field Shield Wound Dressing against standard silver dressings for burn management, enrolling 40 patients at US Army and civilian burn centers.
- US Army Institute for Surgical Research Burn Center (USAISR)primaryArmy burn center and clinical trial site (PI Dr. Leopoldo Cancio) for head-to-head comparison of Field Shield versus standard silver dressings. Located at Ft. Sam Houston Joint Base in San Antonio, TX. Treats approximately 500 burn admissions annually including military personnel injured in the field.
- Valleywise Health Burn CenterprimaryPremier burn center in Phoenix, AZ and clinical trial site (PI Dr. Kevin Foster). 45-bed capacity, cares for 1,200+ inpatients, 3,000 ER patients, and 6,000 outpatients annually. Serves as training ground for U.S. military providing specialty instruction to thousands of military personnel.
- SwineTechsecondaryPrivate label partner producing SwineSeal Liquid Bandage using KeriCure's patented technology for the swine/veterinary market.
- InteliWoundsecondaryPrivate label partner producing BioFilm Blast MD Wound Wash using KeriCure's technology for professional wound care applications.
- Molly's SudsminorPrivate label partner producing Fabric and Hand Sanitizing Spray using KeriCure's technology.
- Defense Health Agency (DHA) / Defense Logistics Agency (DLA)primaryU.S. government agencies that awarded National Stock Numbers (NSNs) to KeriCure products for procurement by DoD, NATO, and federal agencies. Products available through DAPA catalog.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
KeriCure competitors and assessment
Company assessmentBroad incumbents
- Smith+Nephew: Global medical device company with a large advanced wound care portfolio (Allevyn, PICO) sold to hospitals, burn centers, and government channels. Comparable because it competes for the same advanced wound dressing formulary slots as Field Shield and Advanced Shield Chronic.
- Mölnlycke Health Care: Major wound care and surgical solutions company known for Mepilex, Mepitel, and Mepiform dressings. Comparable because it sells advanced wound care products into burn centers, hospitals, and the same long-term care segment that KeriCure targets with Advanced Shield Chronic.
- Integra LifeSciences: Medical technology company with a significant wound care and regenerative tissue portfolio (Integra Dermal Regeneration Template). Comparable because it competes in advanced burn and chronic wound care, including in military and burn center accounts.
- 3M Health Care (Solventum): Spun-off medical division (now Solventum) including Tegaderm transparent dressings and a large advanced wound care line. Comparable because Tegaderm is one of the incumbent products KeriCure's marketing specifically references as a baseline to displace.
- ConvaTec: Wound care, ostomy, and continence care company with products like Aquacel and DuoDERM. Comparable because it competes head-to-head in advanced wound dressings and benefits from the same hospital and home health reimbursement dynamics that drive KeriCure's HCPCS A6248 economics.
- Coloplast: Danish medical device company with a sizable wound and skin care business (Biatain, Comfeel). Comparable because it targets chronic wounds, elderly skin, and the long-term care channel where KeriCure is launching Advanced Shield Chronic Wound Barrier.
Emerging players
- DermaRite Industries: Private manufacturer of wound care, skin care, and barrier products sold into long-term care, home health, and provider channels. Comparable because it competes in the same post-acute and chronic wound care segments where Advanced Shield Chronic Wound Barrier is being launched.
- Covalon Technologies: Smaller medical device company focused on antimicrobial and advanced wound dressings using silver and other technologies. Comparable because it competes at a similar scale and product positioning to KeriCure in the antimicrobial spray-on and coated wound dressing category.
Direct peers
- MiMedx: Regenerative wound care and surgical recovery company (EpiFix, AmnioFix) where KeriCure's founder previously led R&D. Comparable because it sells advanced wound care products to the same hospital, burn, and military channels that KeriCure targets.
- Organogenesis: Regenerative medicine and wound care company (Apligraf, Dermagraft) that sells biologic and advanced wound care products to hospitals, burn centers, and government channels. Comparable because it pursues the same advanced/regenerative wound care positioning and burn center customer base as Field Shield.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
KeriCure social profiles
Digital presenceKeriCure compliance and trust
Trust signalCompliance1 record
KeriCure financial estimates
Financial estimateRevenue estimate
Valuation estimate
KeriCure leadership team
Management profileNumber of profiles
Profiles9 records
KeriCure funding detail
Funding detailFunding overview
Funding rounds4 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KeriCure M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KeriCure
What does KeriCure do?
KeriCure Medical develops and sells proprietary nanopolymer polyacrylate-based spray-on wound care products that combine hydrogel moisture therapy with antimicrobial silver hydrosol and lidocaine for pain relief. The portfolio includes human wound care products (Advanced Seal, Advanced Shield MAX, Advanced Shield Chronic, Field Shield Pro, KeriCleanz) and veterinary lines (Tough Seal, Tough Shield) sold through consumer e-commerce, healthcare provider volume ordering, government contracts, military distributors, and private label licensing.
Is KeriCure a public or private company?
KeriCure is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was KeriCure founded?
KeriCure was founded in 2011. It employs 1 to 10 people.
Where is KeriCure based?
KeriCure is headquartered in Wesley Chapel, United States, in the North America region.
How does KeriCure make money?
Three revenue lines are on record. Product Sales - Consumer/Professional is the primary driver. The others are government Contracts and private Label/Licensing.
Who are KeriCure's main competitors?
Broad incumbents on record are Smith+Nephew, Mölnlycke Health Care, Integra LifeSciences, 3M Health Care (Solventum), ConvaTec and Coloplast. Emerging players are DermaRite Industries and Covalon Technologies. Direct peers are MiMedx and Organogenesis.
Does KeriCure have an API?
No public API is recorded for KeriCure.
What industry is KeriCure in?
KeriCure's product category is Advanced Wound Care Products. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts), with a secondary code of CRADAMAB, First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care). Its NAICS code is 334510 and its SIC code is 3841.